Vista Pharmaceuticals has entered into a joint venture partnership with Pleiades Therapeutics to collaboratively pursue the end-to-end development of Generic Drug Products and Specialty Pharmaceutical Products for regulated as well as rest-of-the-world (ROW) markets.
This strategic partnership aims to synergize the R&D expertise of Pleiades Therapeutics with the robust manufacturing and established marketing presence of Vista Pharmaceuticals in the United States and other key pharmaceutical markets. The collaboration is expected to enhance operational capabilities, expand market reach, and strengthen the competitive positioning of both companies in the global pharmaceutical industry.
Vista Pharmaceuticals is engaged in manufacturing and selling of Pharmaceutical, medical and veterinary preparations. It offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.
